RSM logo
Menopause International

Home Current issue Browse archive Alerts About the journal Feedback
 
Menopause Int 2008;14:40-45
doi:10.1258/mi.2007.007037
© 2008 British Menopause Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rees, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

British Menopause Society Council Consensus Statement

Primary prevention of coronary heart disease in women

Margaret Rees, John Stevenson on behalf of the British Menopause Society Council

Correspondence: Margaret Rees MA DPhil FRCOG, Reader in Reproductive Medicine, Honorary Consultant in Medical Gynaecology, Level 4, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK. Email: margaret.rees{at}obs-gyn.ox.ac.uk
The British Menopause Society Council is committed to provide up-to-date authoritative reviews to aid health professionals to inform and advise women about key issues in postreproductive health. Coronary heart disease (CHD) is a leading cause of death in women. Observational studies have consistently shown estrogen to help prevent CHD in postmenopausal women. The large randomized controlled Women's Health Initiative (WHI) trial did not confirm these observational findings. However, further analyses of the WHI study as well as the observational Nurses' Health Study have now found that the timing of onset of hormone replacement therapy (HRT) use is important and that estrogen may have a protective role in CHD in women aged 50–59 years. This consensus statement will examine the evidence regarding HRT and non-estrogen therapies (lipid lowering agents, aspirin, antihypertensives, antidiabetic medications, selective estrogen receptor modulators [SERMs]) as well as diet, lifestyle and smoking cessation in the primary prevention of CHD in women.

Key Words: Cardiovascular disease • coronary heart disease • postreproductive health • prevention • women


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Menopause IntHome page
J. C Stevenson
Hormone replacement therapy and cardiovascular disease revisited
Menopause Int, June 1, 2009; 15(2): 55 - 57.
[Abstract] [Full Text] [PDF]



Acute CT - A Primer of Emergency Imaging